A Pharmacogenomics Study for Breast Cancer Patients Undergoing Adjuvant Chemotherapy With Doxorubicin (A)/Cyclophosphamide ?) and/or Weekly Paclitaxel.
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2016
At a glance
- Drugs Cyclophosphamide (Primary) ; Doxorubicin (Primary) ; Paclitaxel (Primary)
- Indications Breast cancer
- Focus Adverse reactions; Pharmacogenomic
- 09 Dec 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Dec 2005 New trial record.